ClinVar Miner

Submissions for variant NM_000152.5(GAA):c.2155G>A (p.Ala719Thr)

dbSNP: rs143324027
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000311191 SCV000340065 uncertain significance not provided 2016-03-04 criteria provided, single submitter clinical testing
Invitae RCV001063307 SCV001228145 uncertain significance Glycogen storage disease, type II 2022-07-08 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 719 of the GAA protein (p.Ala719Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with glycogen storage disease type II (PMID: 29149851). ClinVar contains an entry for this variant (Variation ID: 286578). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GAA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Genome-Nilou Lab RCV001063307 SCV002027294 uncertain significance Glycogen storage disease, type II 2021-09-05 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV001063307 SCV002780159 uncertain significance Glycogen storage disease, type II 2021-07-20 criteria provided, single submitter clinical testing
Natera, Inc. RCV001063307 SCV001459750 uncertain significance Glycogen storage disease, type II 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.